← Eichor
Study identifier: NCT06568744 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Fluid Intolerance Signals as Safety Limits to Prevent Fluid-induced Harm During Septic Shock Resuscitation

Condition: Septic Shock  ·  Sponsor: Pontificia Universidad Catolica de Chile

PhaseNA
Planned participants62
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

The goal of this multicentric randomized controlled trial is to compare, in septic shock patients who require further fluid resuscitation, two strategies of administering fluids. The intervention group will integrate fluid intolerance signals to the decision making process, while the control group will follow standard of care, for a 6 hour study protocol. The main question it aims to answer is 1. To compare the effect of both resuscitation strategies on fluid-induced harm, assessed by the change in pulmonary, cardiac, and renal function biomarkers during the study period. 2. To assess the safety of both resuscitation strategies on hypoperfusion resolution, measured by the improvement of capillary refill time (CRT) and lactate during the study period. 3. To determine the dynamics of the different fluid intolerance signals

This description comes directly from the study's public registry record.

Talk to the study team

Eduardo Kattan, MD, PhD  ·  +56223543292  ·  e.kattan@gmail.com

Ricardo Castro, MD  ·  +56223543292  ·  rcastro.med@gmail.com

Always discuss trial participation with your own doctor first.

Locations (3)

Hospital Biprovincial Quillota-PetorcaQuillota, ChileRecruiting
Hospital Barros LucoSantiago, ChileRecruiting
Hospital Clinico UC ChristusSantiago, ChileRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06568744